A Eggermont
Impact in
-
- Immunotherapy and Immune Responses
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
Papers in
-
- Melanoma and MAPK Pathways 3
- Angiogenesis and VEGF in Cancer 1
- S100 Proteins and Annexins 1
- Oncology 5
- Cutaneous Melanoma Detection and Management 3
- Co-authors
- Ulrich Keilholz (2 shared papers)Hans Loibner (1 shared paper)Geoffrey Nichol (1 shared paper)Brent A. Blumenstein (1 shared paper)Giorgio Parmiani (1 shared paper)Natalie Sacks (1 shared paper)Walter J. Urba (1 shared paper)Kristen Hege (1 shared paper)
- Journals
- Journal of Chromatography A (2 papers)Journal of Clinical Oncology (1 paper)Journal of Immunotherapy (1 paper)International Journal of Cancer (1 paper)Melanoma Research (1 paper)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
A Eggermont
8 papers receiving 389 citations
Peers
Comparison fields: 5 of 65
- Immunology 171
- Oncology 190
- Cancer Research 44
- Immunology and Allergy 15
- Molecular Biology 163
Countries citing papers authored by A Eggermont
This map shows the geographic impact of A Eggermont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Eggermont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Eggermont more than expected).
Fields of papers citing papers by A Eggermont
This network shows the impact of papers produced by A Eggermont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Eggermont. The network helps show where A Eggermont may publish in the future.
Co-authors
The 25 scholars most cited alongside A Eggermont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 208 | |
| 2 | 2007 | 56 | |
| 3 | 2000 | 49 | |
| 4 | Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma. | 1994 | 38 |
| 5 | 2002 | 27 | |
| 6 | 2002 | 20 | |
| 7 | [Efficacy of the tumor necrosis factor-alpha (rTNF-alpha) associated with interferon-gamma and chemotherapy in extracorporeal circulation in the limb in inoperable malignant melanoma, soft tissue sarcoma and epidermoid carcinoma. A 4-year experience]. | 1995 | 4 |
| 8 | 1997 | 3 | |
| 9 | Serum S100B protein evaluation in an EORTC randomized melanoma trial: A first report | 2006 | 0 |
About A Eggermont
A Eggermont is a scholar working on Molecular Biology, Oncology, Genetics, Immunology and Allergy and Organic Chemistry, having authored 9 papers that have together received 405 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (3 papers), Cutaneous Melanoma Detection and Management (3 papers), Virus-based gene therapy research (2 papers), Cell Adhesion Molecules Research (2 papers), Angiogenesis and VEGF in Cancer (1 paper), Click Chemistry and Applications (1 paper), Safe Handling of Antineoplastic Drugs (1 paper) and S100 Proteins and Annexins (1 paper). The work is most often cited by research in Immunology (171 citations), Oncology (190 citations), Cancer Research (44 citations), Immunology and Allergy (15 citations) and Molecular Biology (163 citations). A Eggermont has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Ulrich Keilholz, Hans Loibner, Geoffrey Nichol, Brent A. Blumenstein, Giorgio Parmiani, Natalie Sacks, Walter J. Urba, Kristen Hege, Mario Sznol and Axel Hoos. Their work appears in journals such as Journal of Chromatography A, Journal of Clinical Oncology, Journal of Immunotherapy, International Journal of Cancer and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.